GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PT Bundamedik Tbk (ISX:BMHS) » Definitions » Debt-to-EBITDA

PT Bundamedik Tbk (ISX:BMHS) Debt-to-EBITDA : 4.21 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PT Bundamedik Tbk Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

PT Bundamedik Tbk's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was Rp449,554 Mil. PT Bundamedik Tbk's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was Rp705,533 Mil. PT Bundamedik Tbk's annualized EBITDA for the quarter that ended in Mar. 2024 was Rp274,351 Mil. PT Bundamedik Tbk's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 4.21.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for PT Bundamedik Tbk's Debt-to-EBITDA or its related term are showing as below:

ISX:BMHS' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.23   Med: 3.42   Max: 5.51
Current: 5.42

During the past 6 years, the highest Debt-to-EBITDA Ratio of PT Bundamedik Tbk was 5.51. The lowest was 1.23. And the median was 3.42.

ISX:BMHS's Debt-to-EBITDA is ranked worse than
76.35% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 2.58 vs ISX:BMHS: 5.42

PT Bundamedik Tbk Debt-to-EBITDA Historical Data

The historical data trend for PT Bundamedik Tbk's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Bundamedik Tbk Debt-to-EBITDA Chart

PT Bundamedik Tbk Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial 3.53 3.30 1.23 2.88 5.51

PT Bundamedik Tbk Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.02 7.60 5.41 4.51 4.21

Competitive Comparison of PT Bundamedik Tbk's Debt-to-EBITDA

For the Medical Care Facilities subindustry, PT Bundamedik Tbk's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Bundamedik Tbk's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Bundamedik Tbk's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where PT Bundamedik Tbk's Debt-to-EBITDA falls into.



PT Bundamedik Tbk Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

PT Bundamedik Tbk's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(431522.826 + 688430.647) / 203446.232
=5.50

PT Bundamedik Tbk's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(449554.114 + 705532.989) / 274351.208
=4.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


PT Bundamedik Tbk  (ISX:BMHS) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


PT Bundamedik Tbk Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of PT Bundamedik Tbk's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Bundamedik Tbk (ISX:BMHS) Business Description

Traded in Other Exchanges
N/A
Address
Jl. Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.

PT Bundamedik Tbk (ISX:BMHS) Headlines

No Headlines